ATE451464T1 - Verfahren zur erzeugung verankerter proteine - Google Patents

Verfahren zur erzeugung verankerter proteine

Info

Publication number
ATE451464T1
ATE451464T1 AT05713436T AT05713436T ATE451464T1 AT E451464 T1 ATE451464 T1 AT E451464T1 AT 05713436 T AT05713436 T AT 05713436T AT 05713436 T AT05713436 T AT 05713436T AT E451464 T1 ATE451464 T1 AT E451464T1
Authority
AT
Austria
Prior art keywords
anchored proteins
producing
producing anchored
expression vectors
proteins
Prior art date
Application number
AT05713436T
Other languages
English (en)
Inventor
Victoria Yamazaki
Oksana Sirenko
John Groves
Original Assignee
Synamem Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synamem Corp filed Critical Synamem Corp
Application granted granted Critical
Publication of ATE451464T1 publication Critical patent/ATE451464T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT05713436T 2004-02-09 2005-02-09 Verfahren zur erzeugung verankerter proteine ATE451464T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54332404P 2004-02-09 2004-02-09
PCT/US2005/004497 WO2005078104A1 (en) 2004-02-09 2005-02-09 Method for generating tethered proteins

Publications (1)

Publication Number Publication Date
ATE451464T1 true ATE451464T1 (de) 2009-12-15

Family

ID=34860403

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05713436T ATE451464T1 (de) 2004-02-09 2005-02-09 Verfahren zur erzeugung verankerter proteine

Country Status (6)

Country Link
US (1) US20090226960A1 (de)
EP (1) EP1723239B1 (de)
CN (2) CN103255167A (de)
AT (1) ATE451464T1 (de)
DE (1) DE602005018173D1 (de)
WO (1) WO2005078104A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2245182A1 (de) * 2008-02-14 2010-11-03 F. Hoffmann-La Roche AG Vorhersage einer knochenmarktoxizität
KR101857246B1 (ko) * 2015-10-28 2018-05-11 광주과학기술원 인공 사멸세포 수용체 및 이의 용도
WO2018222880A1 (en) 2017-05-31 2018-12-06 Trustees Of Boston University Mechano-activated control of gene expression
CN113923983B (zh) * 2019-04-03 2024-02-27 乔治亚大学研究基金公司 通过细胞外囊泡来递送crispr/mcas9以用于基因组编辑
EP4519294A1 (de) * 2022-05-04 2025-03-12 Earli Inc. Verfahren mit oberflächenexprimierbaren aktivierbaren epitopen zur lokalisierung und/oder behandlung erkrankter zellen

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109113A (en) 1986-05-02 1992-04-28 Genentech, Inc. Membrane anchor fusion polypeptides
US5374548A (en) 1986-05-02 1994-12-20 Genentech, Inc. Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor
US5223394A (en) * 1989-04-10 1993-06-29 Biogen, Inc. Recombinant dna molecule comprising lymphocyte function-associated antigen 3 phosphatidylinositol linkage signal sequence
CA2087545A1 (en) * 1990-07-19 1992-01-20 The Board Of Trustees Of The Leland Stanford Junior University Soluble cell-surface dimeric proteins
HUT73101A (en) 1993-02-12 1996-06-28 Harvard College Method for regulating transcription of targeted genes and other biological events
KR19990022651A (ko) 1995-06-07 1999-03-25 데이비드 엘. 버스테인 생물학적 사건에 대한 라파마이신 기재 조절방법
US5952171A (en) * 1996-11-19 1999-09-14 Millennium Biotherapeutics, Inc. Method for identifying genes encoding secreted or membrane-associated proteins
DE69735601T2 (de) * 1996-11-29 2007-10-18 The Board Of Trustees Of The Leland Stanford Junior University, Stanford Anordnungen von unabhängig voneinander ansteuerbaren, gestützten flüssigbilayer-membranen und ihre anwendungsverfahren
US6503452B1 (en) * 1996-11-29 2003-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biosensor arrays and methods
AU2001264685A1 (en) * 2000-05-18 2001-11-26 The Board Of Trustees Of The Leland Stanford Junior University Lipid bilayer array methods and devices
AU2002240197A1 (en) 2001-02-01 2002-08-12 Tanox, Inc. Methods to generate and identify monoclonal antibodies to a large number of human antigens
US20020160505A1 (en) * 2001-02-16 2002-10-31 Groves John T. Modulation of cellular adhesion with lipid membrane micro-arrays
GB0209023D0 (en) * 2002-04-19 2002-05-29 Oxford Biomedica Ltd Expression vector

Also Published As

Publication number Publication date
WO2005078104A1 (en) 2005-08-25
CN1918299A (zh) 2007-02-21
EP1723239B1 (de) 2009-12-09
EP1723239A1 (de) 2006-11-22
DE602005018173D1 (de) 2010-01-21
CN103255167A (zh) 2013-08-21
US20090226960A1 (en) 2009-09-10
CN1918299B (zh) 2013-04-17

Similar Documents

Publication Publication Date Title
ATE473224T1 (de) Verfahren zur herstellung von nebivolol
MY153295A (en) Nanoparticulated whey proteins
DE602004024181D1 (de) Verfahren zur gewinnung von gallium-68 und dessen verwendung und hilfsmittel zur durchführung dieses verfahrens
EP1730313A4 (de) Verbesserung der proteinexpressionsausbeute in zellfreien proteinsynthesesystemen durch zugabe von antischaummitteln
DE60237184D1 (de) Verfahren zur Erzeugung von Bewegungen
ATE542803T1 (de) Verfahren zur herstellung von dihydrochinazolinen
ATE503454T1 (de) Kosmetische zusammensetzungen und verfahren zu ihrer verwendung zur verbesserung des ästhetischen erscheinungsbilds der haut
ATE508363T1 (de) Verfahren zur herstellung eines bioanalytischen reagenzes, nachweisverfahren beruhend auf der verwendung des bioanalytischen reagenz, sowie dessen verwendung
WO2008093342A3 (en) Albumin fibers and fabrics and methods of generating and using same
DK1557462T3 (da) Transplantataccept-inducerende celler af monocytisk oprindelse, deres fremstilling og anvendelse
EA201290961A1 (ru) Способы применения растворимого cd24 для лечения ревматоидного артрита
ATE541875T1 (de) Strategien zur freisetzung von wirkstoffen unter verwendung von mizellen und partikeln
ATE548353T1 (de) Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon.
DE602005018173D1 (de) Verfahren zur erzeugung verankerter proteine
ATE519784T1 (de) An den humanen igg-fc-rezeptor iib (fcgammariib) bindende substanz
DE602005024824D1 (de) Verfahren zur herstellung von substituierten tetrazolen aus aminotetrazolen
ATE467440T1 (de) Haarstärkungszusammensetzung
DE602005022099D1 (de) Fluorisierungsverfahren zur synthese von 2-ä18fü fluoro-2-deoxy-d-glukose
EP2421467A4 (de) Verfahren zur herstellung und verwendung von dreidimensionalen extrazellulären matrizen
ATE459610T1 (de) Verfahren zur herstellung von alkenylbernsteinsäureanhydriden
DE602006002371D1 (de) Verfahren zur herstellung von brillengläsern
DE602005004235D1 (de) Verfahren zur Erzeugung von Stosswellenformen für Stoss- Ansprechspektrum
ATE438412T1 (de) Zusammensetzung und verfahren zur medizinischen bilddarstellung von körperhöhlen
DE60011785D1 (de) Verfahren zur herstellung von proteinen in wirtszellen unter verwendung von chaperoninen
ATE384802T1 (de) Verfahren zur herstellung von mycophenolat- mofetil mittels enzymatischer umesterung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties